Greenleaf Trust Novartis Ag Transaction History

Greenleaf Trust

$10.9 Billion
Q4 2024

A detailed history of Greenleaf Trust transactions in Novartis Ag stock. As of the latest transaction made, Greenleaf Trust holds 17,793 shares of NVS stock, worth $1.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,793

Previous 17,601 1.09%

Holding current value

$1.78 Million

Previous $2.02 Million 14.48%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$96.78 - $117.18 $18,581 - $22,498	192 Added 1.09%	17,793 $1.73 Million
Q3 2024 Oct 22, 2024	BUY	$106.13 - $120.89 $153,357 - $174,686	1,445 Added 8.94%	17,601 $2.02 Million
Q2 2024 Jul 22, 2024	SELL	$92.57 - $107.37 $112,102 - $130,025	-1,211 Reduced 6.97%	16,156 $1.72 Million
Q1 2024 Apr 29, 2024	SELL	$95.27 - $108.47 $26,485 - $30,154	-278 Reduced 1.58%	17,367 $1.68 Million
Q4 2023 Jan 31, 2024	SELL	$92.27 - $101.54 $1,753 - $1,929	-19 Reduced 0.11%	17,645 $1.78 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $137,832 - $152,964	1,455 Added 8.98%	17,664 $1.8 Million
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $49,220 - $55,812	532 Added 3.39%	16,209 $1.64 Million
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $23,048 - $26,729	-288 Reduced 1.8%	15,677 $1.44 Million
Q4 2022 Jan 25, 2023	SELL	$75.55 - $92.52 $6,572 - $8,049	-87 Reduced 0.54%	15,965 $1.45 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $50,809 - $59,424	681 Added 4.43%	16,052 $1.22 Million
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $71,099 - $82,781	883 Added 6.09%	15,371 $1.3 Million
Q1 2022 Apr 27, 2022	SELL	$80.11 - $90.62 $69,455 - $78,567	-867 Reduced 5.65%	14,488 $1.27 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $464,810 - $513,974	-5,832 Reduced 27.53%	15,355 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $24,779 - $28,827	-303 Reduced 1.41%	21,187 $1.73 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $100,753 - $111,285	-1,182 Reduced 5.21%	21,490 $1.96 Million
Q1 2021 Apr 30, 2021	BUY	$83.5 - $98.47 $188,209 - $221,951	2,254 Added 11.04%	22,672 $1.94 Million
Q4 2020 Feb 08, 2021	BUY	$78.07 - $94.43 $6,167 - $7,459	79 Added 0.39%	20,418 $1.93 Million
Q3 2020 Oct 30, 2020	BUY	$82.14 - $91.0 $28,584 - $31,668	348 Added 1.74%	20,339 $1.77 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $435,888 - $490,664	-5,386 Reduced 21.22%	19,991 $1.75 Million
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $60,988 - $85,445	863 Added 3.52%	25,377 $2.09 Million
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $119,776 - $135,425	-1,420 Reduced 5.48%	24,514 $2.32 Million
Q3 2019 Nov 08, 2019	BUY	$85.54 - $94.26 $31,051 - $34,216	363 Added 1.42%	25,934 $2.25 Million
Q2 2019 Jul 24, 2019	BUY	$75.4 - $92.8 $17,417 - $21,436	231 Added 0.91%	25,571 $2.34 Million
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $216,093 - $247,164	-2,869 Reduced 10.17%	25,340 $2.44 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $624,636 - $695,529	8,480 Added 42.98%	28,209 $2.42 Million
Q3 2018 Oct 29, 2018	BUY	$66.94 - $77.43 $600,184 - $694,237	8,966 Added 83.3%	19,729 $1.7 Million
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $158,769 - $179,438	-2,446 Reduced 18.52%	10,763 $813,000
Q1 2018 Apr 30, 2018	BUY	$70.39 - $84.15 $95,308 - $113,939	1,354 Added 11.42%	13,209 $1.07 Million
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $198,618 - $213,199	-2,746 Reduced 18.81%	11,855 $995,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.08 Million - $1.13 Million	14,601	14,601 $1.25 Million

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account